Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been formally diagnosed with Parkinson's disease using recognised international diagnostic guidelines.
- People who have been living with Parkinson's disease for at least 4 years.
- People who a medical team has determined are suitable candidates for a type of brain surgery called deep brain stimulation (DBS) of a specific brain region, based on an established surgical assessment program.
- People aged between 18 and 75 years.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are not able to give informed consent to participate.
- People who have moderate or severe memory or thinking difficulties (specifically, a score below 24 on a standard cognitive test called the Mini-Mental State Examination).
- People who are experiencing significant psychiatric symptoms, such as psychosis or major depression.
- People who have previously had brain surgery related to Parkinson's disease.
- People who are pregnant.
- People who have ongoing inflammatory or autoimmune conditions (confirm with trial site).
- People who have a long-term infectious disease.
- People who currently have an active cancer.
- People who regularly take anti-inflammatory medications, such as steroids or drugs like ibuprofen (known as NSAIDs).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: francesco Bove, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phone: +390630154303
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
To characterize neuroinflammatory effects of deep brain stimulations
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.